Advertisement

Topics

In RA, No Added Second Malignancy Risk With Biologics

09:50 EST 14 Nov 2017 | Cancer Networks

Some physicians have shown reluctance to use these agents for patients who have rheumatoid arthritis and a previous cancer diagnosis.

Original Article: In RA, No Added Second Malignancy Risk With Biologics

NEXT ARTICLE

More From BioPortfolio on "In RA, No Added Second Malignancy Risk With Biologics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...